ÌÇÐÄVlog

Treatment for Ewing Sarcoma Adding Topotecan to Chemotherapy

Clinical Trial

Offered by: ±·±ð³¾´Ç³Ü°ù²õÌý°ä³ó¾±±ô»å°ù±ð²Ô'²õÌý
Locations: Delaware Valley and Pensacola, FL

Trial Name

A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma

What is the trial about?

Improve the treatment for Ewing sarcoma by adding another drug called topotecan to the drugs used in standard treatment.

Who can participate?

Children with Ewing sarcoma.

What is involved?

Length of study is nine months. Standard cancer care.

Contact ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's Clinical Trials

Trial Name: A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma

COG#: AEWS1031

Is a Clinical Trial Right for Your Child?

Learn more about clinical trials and get answers to questions you might have.

Two researchers in a lab wearing coats and gloves, one looks into a microscope.